Jérôme Estaquier
Chercheur universitaire
Axe Maladies infectieuses et immunitaires
Dernières nouvelles
Voir toutPublications
Voir tout-
article Hendrickx S, Ilbeigi K, Thoré ESJ, Bertram MG, Calvo-Alvarez E, Cintesun S, Olías-Molero AI, Corral MJ, Mateo-Barrientos M, Estaquier J, Pomel S, Alunda JM, Gul S, Van Bocxlaer K, Frézard F, Tavares J, Cordeiro Da Silva A, Costi MP, Maes L, Caljon G
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate
J Antimicrob Chemother 81 (6), 2026.
-
article Hendrickx S, Ilbeigi K, Thoré ESJ, Bertram MG, Calvo-Alvarez E, Cintesun S, Olías-Molero AI, Corral MJ, Mateo-Barrientos M, Estaquier J, Pomel S, Alunda JM, Gul S, Van Bocxlaer K, Frézard F, Tavares J, Da Silva AC, Costi MP, Maes L, Caljon G
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 1: setting the stage
J Antimicrob Chemother 81 (5), 2026.
-
article Hendrickx S, Ilbeigi K, Thoré ESJ, Bertram MG, Calvo-Alvarez E, Cintesun S, Olías-Molero AI, Corral MJ, Mateo-Barrientos M, Estaquier J, Pomel S, Alunda JM, Gul S, Van Bocxlaer K, Frézard F, Tavares J, Cordeiro Da Silva A, Costi MP, Maes L, Caljon G
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit
J Antimicrob Chemother 81 (4), 2026.
Projets
- National Primate Center for Pandemic Preparedness (NPCPP), du 2024-03-01 au 2028-03-31
- Pre-clinical tools and services for deciphering the repertoires of B and T cells elicited by the immune response in non-human primates (NHP), du 2025-04-08 au 2027-06-30
- Canadian HIV Cure Enterprise 3.0: Targeting tissue HIV reservoirs, du 2025-01-01 au 2029-12-31
- Deciphering the genomic and immunological factors contributing to asymptomatic Leishmania infantum infections in humans, du 2025-04-01 au 2027-03-31
- Chaire de recherche du Canada en physiopathologie de la mort cellulaire dans les interactions hôtes-pathogènes, du 2018-04-01 au 2025-03-31
- Canadian HIV Cure Enterprise 2.0: Targeting the interplay between myeloid cells and C04+ T-cells for HIV cure, du 2019-04-01 au 2025-03-31
- Therapeutic approach to preserve Tfh cells and improve B cell immunity in simian immunodeficiency virus infected rhesus macaques, du 2021-04-01 au 2026-03-31
- Prevention of the immunopathology induced by SARS-CoV-2, du 2021-06-01 au 2025-03-31
- Metabolism of transcriptionally active cells associated with viral reactivation in lymphoid tissues. An approach to cure AIDS, du 2025-02-01 au 2026-01-31